Evidence map›Paper›PMID 31791327›Full record

ArticleRespiratory research2019

DNA methylation is associated with lung function in never smokers.

Maaike de Vries, Ivana Nedeljkovic, Diana A van der Plaat, Alexandra Zhernakova, Lies Lahousse, Guy G Brusselle, BIOS Consortium, Najaf Amin, Cornelia M van Duijn, Judith M Vonk and 1 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Respiratory research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Association of Methylation Level in thePharmacogenomics and personalized medicine · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Current views in chronic obstructive pulmonary disease pathogenesis and management.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2021
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Maaike de VriesUniversity of Groningen, University Medical Center Groningen, Department of Epidemiology, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands. m.de.vries04@umcg.nl.ORCID http://orcid.org/0000-0001-7210-8174
Ivana NedeljkovicDepartment of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Diana A van der PlaatUniversity of Groningen, University Medical Center Groningen, Department of Epidemiology, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
Alexandra ZhernakovaUniversity of Groningen, University Medical Center Groningen, Department of Genetics, Groningen, The Netherlands.
Lies LahousseDepartment of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Guy G BrusselleDepartment of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
BIOS Consortium
Najaf AminDepartment of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Cornelia M van DuijnDepartment of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
Judith M VonkUniversity of Groningen, University Medical Center Groningen, Department of Epidemiology, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
H Marike BoezenUniversity of Groningen, University Medical Center Groningen, Department of Epidemiology, Hanzeplein 1, 9713 GZ, Groningen, The Netherlands.
University Medical Center Groningen · NLErasmus MC · NLGhent University Hospital · BE

Funding

Longfonds 4.1.13.007
6 · The paper itself

Abstract

backgroundActive smoking is the main risk factor for COPD. Here, epigenetic mechanisms may play a role, since cigarette smoking is associated with differential DNA methylation in whole blood. So far, it is unclear whether epigenetics also play a role in subjects with COPD who never smoked. Therefore, we aimed to identify differential DNA methylation associated with lung function in never smokers.

methodsWe determined epigenome-wide DNA methylation levels of 396,243 CpG-sites (Illumina 450 K) in blood of never smokers in four independent cohorts, LifeLines COPD&C (N = 903), LifeLines DEEP (N = 166), Rotterdam Study (RS)-III (N = 150) and RS-BIOS (N = 206). We meta-analyzed the cohort-specific methylation results to identify differentially methylated CpG-sites with FEV

resultsA total of 36 CpG-sites were associated with FEV

conclusionsWith the identification of 35 CpG-sites that are unique for never smokers, our study shows that DNA methylation is also associated with FEV

Indexed as

AdultCohort StudiesCpG IslandsDNA MethylationEpigenesis, GeneticFemaleForced Expiratory VolumeGenome-Wide Association StudyHumansMaleMiddle AgedPulmonary Disease, Chronic ObstructiveReference ValuesSmokersSmokingCOPDDNA methylationEWASFEV1/FVCNever smokers

Identifiers

PMID31791327
PMCPMC6889726
OpenAlexW2992500799

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.